NCT07128615 - A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) | Biotech Hunter

Enrollment

400

Participants

Timeline

Start Date

September 4, 2025

Primary Completion Date

January 29, 2026

Study Completion Date

January 7, 2027

Conditions

Influenza A

Interventions

BIOLOGICAL

AZD4117

Intramuscular (IM) injection

BIOLOGICAL

AZD5315

IM injection

OTHER

Placebo

IM injection

Trial Locations (14)

29405

NOT_YET_RECRUITING

Research Site, North Charleston

30281

NOT_YET_RECRUITING

Research Site, Stockbridge

33012

RECRUITING

Research Site, Hialeah

45212

RECRUITING

Research Site, Cincinnati

60640

RECRUITING

Research Site, Chicago

64114

RECRUITING

Research Site, Kansas City

66219

RECRUITING

Research Site, Lenexa

68134

NOT_YET_RECRUITING

Research Site, Omaha

73013

NOT_YET_RECRUITING

Research Site, Edmond

78745

NOT_YET_RECRUITING

Research Site, Austin

84088

RECRUITING

Research Site, West Jordan

89119

RECRUITING

Research Site, Las Vegas

90274

RECRUITING

Research Site, Rolling Hills Estates

90815

RECRUITING

Research Site, Long Beach